Z6·尊龙凯时「中国」官方网站z6尊龙

|
EN
|
EN
EN
  • 业务咨询

    中国:

    Email: marketing@kangtya.com

    业务咨询专线:400-780-8018

    (仅限服务咨询,其他事宜请拨打川沙总部电话)

    川沙总部电话: +86 (21) 5859-1500

    海外:

    +1(626)986-9880(U.S. - West Coast)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

在线留言×
点击切换
News information
新闻资讯

KRAS的信号通路

2023-12-19
|
访问量:

KRAS信号的激活是一个多步骤的过程,需要适当的KRAS翻译后修饰,细胞膜定位与效应蛋白的相互作用。

The activation of KRAS signaling is a multi-step process that requires proper KRAS post-translation,plasma membrane-localization and interaction with effector proteins.

在细胞外刺激作用下,从失活的RAS-GDP到激活的RAS-GDP的转化进一步促进了多种信号通路的激活,包括MAPK通路、PI3k 通路和Ral-GEFs通路,其中以MAPK通路的特征最为明显。

In response to extracellular stimuli, the conversion from inactive RAS-GDP to active RAS-GDP further promotes the activation of various signaling pathways, which includes MAPK pathway,PI3k pathway and the Ral-GEFs pathway,among them the MAPK pathway is the best characterized.

RAS-GDP直接与RAF蛋白结合,将RAF激酶家族从细胞质招募到膜上,在细胞膜上二聚化并活化。激活的RAF随后对其下游底物,即MEK and ERk进行一系列磷酸化反应,并传导生长信号。

RAS-GDP directly binds to RAF protein,recruiting RAF Kinese family from cytoplasm to membranes,where they dimerize and become active. The activated RAF subsequently carries out a chain of phospholation reactions to its downstream substrates, MEK and ERk, and propagates the growth signal.

更多“KRAS靶点”相关内容推荐

KRAS新药研发平台

什么是KRAS?

z6尊龙助力信诺维抗肿瘤1类新药XNW14010(小分子KRAS G12C蛋白共价结合抑制剂)获批临床

相关新闻
网站首页
z6尊龙